GlassScriptPhysician profile
William T Mccutchen
NPI 1326084633
$271.45
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $22.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $59.70 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $41.02 | 2019 | |
| Coloplast Corp | $28.20 | 2019 | |
| Medtronic USA, INC. | $27.34 | 2019 | |
| Endo Pharmaceuticals INC. | $18.46 | 2019 | |
| Amgen INC. | $16.54 | 2019 | |
| Olympus America INC. | $15.00 | 2019 | |
| Janssen Biotech, INC. | $14.52 | 2019 | |
| Axogen | $14.08 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.06 | 2019 | |
| Novo Nordisk INC | $11.58 | 2019 | |
| Therapeuticsmd, INC. | $10.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mccutchen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.